(Q34101885)

English

Boosting endogenous neuroprotection in multiple sclerosis: the ASsociation of Inosine and Interferon beta in relapsing- remitting Multiple Sclerosis (ASIIMS) trial

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Boosting endogenous neuroprotection in multiple sclerosis: the ASsociation of Inosine and Interferon beta in relapsing- remitting Multiple Sclerosis (ASIIMS) trial (English)

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

multiple sclerosis

0 references

relapsing-remitting multiple sclerosis

0 references

Marie B D'hooghe

object named as

Marie B D'hooghe

3

0 references

author name string

Richard E Gonsette

1

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Christian Sindic

2

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Peter-Paul De Deyn

4

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Robert Medaer

5

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Alex Michotte

6

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Pierrette Seeldrayers

7

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Daniel Guillaume

8

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

ASIIMS study group

9

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

publication date

3 March 2010

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Multiple Sclerosis Journal

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

16

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

4

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

455-462

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Towards the physiological function of uric acid

1 reference

https://api.crossref.org/works/10.1177%2F1352458509360547

21 January 2018

Neurodegeneration in multiple sclerosis: the role of oxidative stress and excitotoxicity

1 reference

https://api.crossref.org/works/10.1177%2F1352458509360547

21 January 2018

Uric acid, a natural scavenger of peroxynitrite, in experimental allergic encephalomyelitis and multiple sclerosis

1 reference

https://api.crossref.org/works/10.1177%2F1352458509360547

21 January 2018

Serum uric acid and multiple sclerosis

1 reference

https://api.crossref.org/works/10.1177%2F1352458509360547

21 January 2018

Uric acid in multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1177%2F1352458509360547

21 January 2018

Prevention of experimental allergic encephalomyelitis by targeting nitric oxide and peroxynitrite: implications for the treatment of multiple sclerosis

1 reference

https://api.crossref.org/works/10.1177%2F1352458509360547

21 January 2018

Uric acid provides an antioxidant defense in humans against oxidant- and radical-caused aging and cancer: a hypothesis

1 reference

https://api.crossref.org/works/10.1177%2F1352458509360547

21 January 2018

Recommended diagnostic criteria for multiple sclerosis: Guidelines from the international panel on the diagnosis of multiple sclerosis

1 reference

https://api.crossref.org/works/10.1177%2F1352458509360547

21 January 2018

Tables of the number of patients required in clinical trials using the logrank test.

1 reference

https://api.crossref.org/works/10.1177%2F1352458509360547

21 January 2018

Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS)

1 reference

https://api.crossref.org/works/10.1177%2F1352458509360547

21 January 2018

Development of a multiple sclerosis functional composite as a clinical trial outcome measure

1 reference

https://api.crossref.org/works/10.1177%2F1352458509360547

21 January 2018

Serum uric acid, dehydroepiandrosterone sulphate, and apolipoprotein E genotype in benign vs. progressive multiple sclerosis

1 reference

https://api.crossref.org/works/10.1177%2F1352458509360547

21 January 2018

Uric acid levels in sera from patients with multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1177%2F1352458509360547

21 January 2018

Serum uric acid levels in multiple sclerosis patients correlate with activity of disease and blood-brain barrier dysfunction

1 reference

https://api.crossref.org/works/10.1177%2F1352458509360547

21 January 2018

Serum uric acid and multiple sclerosis

1 reference

https://api.crossref.org/works/10.1177%2F1352458509360547

21 January 2018

Variation of serum uric acid levels in multiple sclerosis during relapses and immunomodulatory treatment

1 reference

https://api.crossref.org/works/10.1177%2F1352458509360547

21 January 2018

Therapeutic intervention in experimental allergic encephalomyelitis by administration of uric acid precursors.

1 reference

https://api.crossref.org/works/10.1177%2F1352458509360547

21 January 2018

Uric acid is reduced in the substantia nigra in Parkinson's disease: effect on dopamine oxidation

1 reference

https://api.crossref.org/works/10.1177%2F1352458509360547

21 January 2018

Nigral glutathione deficiency is not specific for idiopathic Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1177%2F1352458509360547

21 January 2018

Kynurenic acid concentrations are reduced in Huntington's disease cerebral cortex

1 reference

https://api.crossref.org/works/10.1177%2F1352458509360547

21 January 2018

Measurement of low-molecular-weight antioxidants, uric acid, tyrosine and tryptophan in plaques and white matter from patients with multiple sclerosis

1 reference

https://api.crossref.org/works/10.1177%2F1352458509360547

21 January 2018

Severe oxidative damage in multiple sclerosis lesions coincides with enhanced antioxidant enzyme expression.

1 reference

https://api.crossref.org/works/10.1177%2F1352458509360547

21 January 2018

Interferon-beta and neuroprotection in multiple sclerosis--facts, hopes and phantasies

1 reference

https://api.crossref.org/works/10.1177%2F1352458509360547

21 January 2018

Boosting T-cell immunity as a therapeutic approach for neurodegenerative conditions: the role of innate immunity

1 reference

https://api.crossref.org/works/10.1177%2F1352458509360547

21 January 2018

Immunoglobulins and complement in postmortem multiple sclerosis tissue

1 reference

https://api.crossref.org/works/10.1177%2F1352458509360547

21 January 2018

The Nrf2-antioxidant response element signaling pathway and its activation by oxidative stress

1 reference

https://api.crossref.org/works/10.1177%2F1352458509360547

21 January 2018

The role of kynurenines in disorders of the central nervous system: possibilities for neuroprotection

1 reference

https://api.crossref.org/works/10.1177%2F1352458509360547

21 January 2018

Preferential loss of myelin-associated glycoprotein reflects hypoxia-like white matter damage in stroke and inflammatory brain diseases.

1 reference

https://api.crossref.org/works/10.1177%2F1352458509360547

21 January 2018

The endocannabinoid system and multiple sclerosis

1 reference

https://api.crossref.org/works/10.1177%2F1352458509360547

21 January 2018

The treatment of multiple sclerosis with inosine

1 reference

https://api.crossref.org/works/10.1177%2F1352458509360547

21 January 2018

The role of oxidative stress in the pathogenesis of multiple sclerosis: the need for effective antioxidant therapy

1 reference

https://api.crossref.org/works/10.1177%2F1352458509360547

21 January 2018

Antioxidant therapy in multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1177%2F1352458509360547

21 January 2018

Randomised double-blind placebo-controlled study of interferon β-1a in relapsing/remitting multiple sclerosis

1 reference

https://api.crossref.org/works/10.1177%2F1352458509360547

21 January 2018

Identifiers

10.1177/1352458509360547

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

release_nnk6cpduvjb6jmqp3a55cgjjv4

1 reference

https://api.fatcat.wiki/v0/release/nnk6cpduvjb6jmqp3a55cgjjv4

24 November 2022

based on heuristic

mapped directly with Wikidata item

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34101885&oldid=1954506017"